Search results
Family's anger at hospital over death of gran, 92
BBC via Yahoo News· 7 days agoShe was moved to Pendle Community Hospital on 10 June. Mrs Clement then suffered significant internal bleeding and was transferred to the Royal Blackburn...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
telegraphherald.com· 4 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
Family's anger at Nelson hospital over death of gran, 92
BBC News· 7 days agoThe family of a 92-year-old woman whom hospital staff failed to care for properly before she died...
3D-printed grafts: a breakthrough in combating pos | Newswise
Newswise· 5 days agoA new study presents the development of 3D printed electrospun vascular grafts infused with...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoBlueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT®/AYVAKYT® (avapritinib) PR Newswire CAMBRIDGE, Mass., May ...
Don't let bed bugs wreck your summer vacation. Here's how to avoid these bloodsuckers
The Arizona Republic· 7 days agoBed bugs can turn up anywhere, including the nicest looking hotels and vacation rentals....
Blueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting...
Benzinga· 5 days ago-- Breadth of data across 7 presentations, including 4 oral, reflects continued leadership in advancing the understanding and treatment of systemic mastocytosis -- CAMBRIDGE, Mass., May 30, 2024 /PRNewswire/ -- Blueprint